Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial

BACKGROUND: Oral mucositis (OM) in patients receiving cancer therapy is thus far not well managed with standard approaches. We aimed to assess the safety and effectiveness of methylene blue (MB) oral rinse for OM pain in patients receiving cancer therapy. METHODS: In this randomized, single-blind ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Roldan, Carlos J., Huh, Billy, Song, Juhee, Nieto, Yago, Osei, Joyce, Chai, Thomas, Nouri, Kent, Koyyalagunta, Lakshmi, Bruera, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632023/
https://www.ncbi.nlm.nih.gov/pubmed/36324139
http://dx.doi.org/10.1186/s12916-022-02579-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632023/
https://www.ncbi.nlm.nih.gov/pubmed/36324139
http://dx.doi.org/10.1186/s12916-022-02579-8

Ejemplares similares